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a b s t r a c t 
Structural and functional alterations of the brain in persons genetically at-risk for Alzheimer’s disease (AD) are 
crucial in unravelling AD development. Filippini et al. found that the default mode network (DMN) is already af- 
fected in young APOE 𝜀 4-carriers, with increased co-activation of the DMN during rest and increased hippocampal 
task activation. We aimed to replicate the early findings of Filippini et al, using the APOE gene, still the principal 
AD risk gene, and extended this with a polygenic risk score (PRS) analysis for AD, using the Human Connectome 
Project dataset (HCP). We included participants from the HCP S1200 dataset (age range: 22-36 years). We studied 
morphometric features, functional DMN co-activation and functional task activation of recollection performance. 
Permutation Analysis of Linear Models (PALM) was used to test for group differences between APOE 𝜀 4-carriers 
and non-carriers, and to test the association with PRS. PALM controls for biases induced by the family structure 
of the HCP sample. Results were family-wise error rate corrected at p < 0.05. Our primary analysis did not repli- 
cate the early findings of Filippini et al. (2009). However, compared with non-carriers, APOE 𝜀 4-carriers showed 
increased functional activation during the encoding of subsequently recollected items in areas related to facial 
recognition (p < 0.05, t > 756.11). This increased functional activation was also positively associated with PRS 
(APOE variants included) (p < 0.05, t > 647.55). Our results are supportive for none to limited genetic effects on 
brain structure and function in young adults. Taking the methodological considerations of replication studies into 
account, the true effect of APOE 𝜀 4-carriership is likely smaller than indicated in the Filippini paper. However, 
it still holds that we may not yet be able to detect already present measurable effects decades before a clinical 
expression of AD. Since the mechanistic pathway of AD is likely to encompass many different factors, further 
research should be focused on the interactions of genetic risk, biomarkers, aging and lifestyle factors over the life 
course. Sensitive functional neuroimaging as used here may help disentangling these complex interactions. 
1. Introduction 
Dementia is a syndrome that encompasses a set of symptoms, such 
as cognitive decline and behavioural changes, reducing a person’s 
ability to perform activities of daily living ( Winblad et al., 2016 ). In 
the ageing population, the number of older adults with dementia is 
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expected to rise ( Patterson, 2018 ). Worldwide, 50 million people are 
currently living with dementia and this number is predicted to triple 
by 2050, making dementia a global health priority ( Patterson, 2018 ; 
Wortmann, 2012 ). Alzheimer’s disease (AD) is the main cause of demen- 
tia, accounting for 50-70% of dementia cases ( Hendrie, 1998 ; Winblad 
et al., 2016 ). 
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Received 12 May 2021; Received in revised form 27 May 2021; Accepted 22 June 2021 
Available online 27 June 2021. 
1053-8119/© 2021 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) 
L.J. Mentink, J.P.O.F.T. Guimarães, M. Faber et al. NeuroImage 240 (2021) 118304 
High heritability of late-onset AD was reported by twin studies (es- 
timated between 60% and 78%) and by SNP-based approaches (es- 
timated between 12% and 53%), with the apolipoprotein E (APOE) 
gene, thus forming an important genetic risk factor ( Anttila et al., 2018 ; 
Farrer et al., 1997 ; Gatz et al., 1997 , 2006 ; Lee et al., 2012 ; Liu et al., 
2013 ; Ridge et al., 2016 , 2013 ). The APOE gene has three common alle- 
les, 𝜀 2, 𝜀 3 and 𝜀 4, with frequencies in the general population of 6%, 
78% and 15%, respectively ( Eisenberg et al., 2010 ). The 𝜀 4-allele is 
genetically associated with late-onset AD, with an odds ratio (OR) of 
2.6 to 3.2 for 𝜀 4 heterozygotes and an OR of 12.5 for 𝜀 4 homozygotes, 
compared to 𝜀 3 homozygotes ( Corder et al., 1993 ; Farrer et al., 1997 ; 
Liu et al., 2013 ). The 𝜀 2-allele is thought to be a protective factor for 
developing AD (OR 0.6 compared to 𝜀 3 homozygotes) ( Corder et al., 
1993 ; Farrer et al., 1997 ; Liu et al., 2013 ). In addition to the APOE gene, 
multiple other genetic variants have been identified in genome-wide as- 
sociation studies that significantly modify the risk of AD ( Desikan et al., 
2015 ; Guerreiro et al., 2013 ; Jansen et al., 2019 ; Jonsson et al., 2012 ; 
Lambert et al., 2013 ; Liu et al., 2017 ; Sims et al., 2017 ). 
Previous neuroimaging studies have reported structural and func- 
tional alterations in middle-aged and older APOE 𝜀 4-carriers, such 
as decreased hippocampal volume, decreased entorhinal cortex thick- 
ness and altered resting-state network activation ( Bookheimer and 
Burggren, 2009 ; Filippini et al., 2009 ; Trachtenberg et al., 2012 ; 
Yu et al., 2014 ). Resting state networks (RSN) consist of spatially dis- 
tinct brain regions that show synchronous temporal signal fluctuations 
during rest, which can be measured with fMRI ( Beckmann et al., 2005 ; 
Raichle et al., 2001 ). A specific RSN is the default mode network (DMN), 
which comprises the anterior cingulate cortex, posterior cingulate cor- 
tex, precuneus, medial prefrontal cortex, retrosplenial cortex, parietal 
cortex and mediotemporal lobe regions ( Hafkemeijer et al., 2012 ). The 
DMN is known to be affected in neurodegenerative processes; regions 
of the DMN are among the first to show amyloid-beta deposition and 
vulnerability to atrophy ( Buckner et al., 2005 ; Greicius et al., 2004 ; 
Jones et al., 2011 ; Palmqvist et al., 2017 ). Deactivation of the DMN 
increases during transition from normal aging to mild cognitive impair- 
ment (MCI) and AD ( Hafkemeijer et al., 2012 ). Possible alterations of 
the DMN in young adults genetically at-risk for AD are crucial in unrav- 
elling AD development, before confounding factors of older age and AD 
itself are present. 
Filippini et al. reported that the DMN is already affected in young 
APOE 𝜀 4-carriers ( Filippini et al., 2009 ). Specifically, using resting-state 
fMRI, the authors found an increase in DMN co-activation in the medial 
temporal lobe regions and medial prefrontal and retrosplenial cortices. 
In addition, fMRI activation during a novel vs. familiar memory-retrieval 
paradigm was increased in the hippocampal region for APOE 𝜀 4-carriers 
compared to non-carriers. Filippini et al. suggested that these results 
could reflect a compensation mechanism. No differences were found 
in total gray matter volume and hippocampal volume ( Filippini et al., 
2009 ). Even though this study only assessed a small sample size of 18 
APOE 𝜀 4-carriers and 18 matched controls, it has become a landmark 
paper with many neuroscience papers citing this finding to illustrate the 
trajectory of functional alterations of the DMN in APOE 𝜀 4-carriers from 
young adults and normal aging to MCI and AD ( Damoiseaux et al., 2012 ; 
Hafkemeijer et al., 2012 ; Sperling et al., 2010 ). While multiple studies 
have been performed on DMN activation in older adults and adults with 
MCI or AD, there are few studies on the effect of APOE 𝜀 4 on the DMN in 
young, healthy adults, of which Filippini et al. is the most highly cited 
( Filippini et al., 2009 ; Hafkemeijer et al., 2012 ; Hodgetts et al., 2019 ; 
Su et al., 2015 ). 
In this paper, we aimed to replicate the results found by Filippini 
et al. using the dataset of the Human Connectome Project (HCP) and ad- 
ditionally combine a broad variety of genetic variants that confer risk for 
AD in a polygenic risk score (PRS) to study the mechanism between ge- 
netic risk and AD development in a more sensitive manner (; ). Our study 
benefited from a large sample size, advanced data quality and additional 
improved preprocessing methods, especially regarding data denoising. 
Filippini et al. established state-of-the-art statistical procedures for rest- 
ing state connectivity analyses, which are still used today. We adhered 
to these methods as much as possible. Results of the memory-encoding 
paradigm could not be replicated directly, but the HCP dataset contains 
a working memory task combined with a post-hoc item recognition 
task that was used as an indirect replication; using a different mem- 
ory task to replicate previous findings adds more confidence to the 
generalisability of the findings than a direct replication. 
The HCP dataset represents the population at large and therefore en- 
abled us to not only replicate the Filippini paper with substantially in- 
creased power, but also to study the polygenic nature of any effects and 
the generalisability of these results, as a broad spectrum of behavioural 
and demographic variations can be observed in the HCP cohort. 
For our study we hypothesise the following: 
1. No association of gray matter volumes in young adults with APOE 
𝜀 4 genotypes or with PRS. 
2. Increased co-activation of the DMN during rest, in the medial tem- 
poral lobe regions and medial prefrontal and retrosplenial cortices 
specifically, in APOE 𝜀 4-carriers and participants with a high PRS. 
3. Increased hippocampal activation during encoding, with a 0-back 
task, leading to recollection at the item recognition task, in APOE 
𝜀 4-carriers and participants with a high PRS. 
2. Methods 
2.1. Replication 
Advances in MRI data acquisition and analyses necessitate de- 
viations from the exact methods used by Filippini et al. The HCP 
acquired high quality MR data, which should have had little impact 
on replication results. The standard minimal preprocessing of the HCP 
data differed on several points: The standard minimal preprocessing 
included spatial distortion correction, global intensity normalisation, 
smoothing using 2mm full-width half-maximum (FWHM) instead of 
6mm FWHM and artefact removal using FSL’s ICA-based artefact 
removal (ICA + FIX). The improved preprocessing resulted in less noise 
in the data, which were advantageous for replication results. The data 
was stored in CIFTI files, instead of the more common NIFTI file type. 
CIFTI files store the data as grayordinates instead of voxels, therefore 
the data could be handled as surface data instead of volume data, which 
also improved group-based results with reduced noise and more precise 
spatial correspondence between subjects (see ( Glasser et al., 2013 ) ). 
Furthermore, the memory performance was indirectly assessed as the 
same task was not available in the HCP database. In the study of Filippini 
et al., participants encoded eight images before the task fMRI. During 
the task fMRI, both familiar and novel items were shown. Main contrast 
of interest was the task activation of novel vs. familiar images. In our 
study, the encoding of the images was performed during the task fMRI, 
and the memory task was performed afterwards. We used the memory 
task results to identify items that were successfully or unsuccessfully 
encoded, as well as successfully encoded items that were recollected 
versus just familiar, and compared the encoding activity between these 
item-groups. Even though the task activation was measured in a differ- 
ent part of the memory paradigm, we deemed this analysis as relevant, 
as hippocampal activation is present in periods of both encoding and 
memory recall ( Bookheimer et al., 2000 ). In addition to this, Filippini 
et al. investigated the resting brain perfusion using perfusion MRI. How- 
ever, perfusion MRI is not available in the HCP dataset and perfusion 
results could therefore not be replicated. Any other deviations from the 
methods used in Filippini et al. were indicated as such. 
2.2. Participants 
We used the dataset collected as part of the WU-Minn HCP (S-1200 
release), consisting of close to 1200 healthy young adults in the age 
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Fig. 1. Schematic overview of the analyses. 
range of 22-35 years ( Van Essen et al., 2013 ). The HCP aimed for a 
sample representing the population at large, which allowed us to study 
whether the effect found by Filippini et al. generalises to a large pop- 
ulation. We included participants if the following data were available: 
complete demographic information, a T1-weighted structural scan, four 
fully completed 3T resting-state fMRI scans and a completed working- 
memory task fMRI scan. We excluded participants with anatomical 
anomalies and segmentation and surface errors in the data (Quality is- 
sues A + B) and if the MR images were not reconstructed using the im- 
proved image reconstruction algorithm (r227). Participants with at least 
one 𝜀 4-allele were included as carriers, participants with two 𝜀 3-alleles 
as non-carriers. Participants with the 𝜀 2-allele were not included, be- 
cause of the protective effects of the 𝜀 2-allele ( Corder et al., 1994 ). These 
in- and exclusion criteria led to a sample size ranging from 454 to 787 
participants for the different analyses ( Fig. 1 ). 
2.3. Neuroimaging protocol 
Participants were scanned on a 3T MR scanner with a stan- 
dard 32-channel head coil at Washington University (Connectome 
Skyra, Siemens, Germany). The neuroimaging protocol consisted of 
structural MRI, resting-state fMRI and task fMRI ( Human Connec- 
tome Project, 2017 ; Van Essen et al., 2013 ). 
2.3.1. Structural MRI 
A T1-weighted MRI scan was acquired using a magnetization- 
prepared rapid gradient echo sequence (TR = 2400 ms, TR = 2.14 ms, 
flip angle = 8, field of view = 224 mm, voxel size = 0.7 mm isotropic, 
acquisition time = 7 min 40 sec) ( Human Connectome Project, 2017 ). 
2.3.2. Resting-state fMRI 
Resting-state fMRI data were acquired in four runs. The resting-state 
images were acquired using a gradient-echo EPI sequence (TR = 720 ms, 
TE = 33.1 ms, flip angle = 52, field of view = 208 × 180 mm, voxel 
size = 2.0 mm isotropic, multiband factor = 8, acquisition time = 14 min 
33 sec per run) ( Human Connectome Project, 2017 ; Smith et al., 2013 ). 
2.3.3. Task fMRI 
The task images for working memory were acquired in two runs (LR 
and RL phase encoding direction) using a gradient-echo EPI sequence, 
with 405 frames per run (TR = 720 ms, TE = 33.1 ms, flip angle = 52, 
field of view = 208 × 180 mm, voxel size = 2.0 mm isotropic, multiband 
factor = 8, acquisition time = 5 min 1 sec per run) ( Human Connec- 
tome Project, 2017 ). 
2.3.4. Encoding task 
The participants performed a working memory task (N-back task 
with 2-back and 0-back levels) during the task fMRI scan with four stim- 
ulus types (faces, places, tools and body parts), shown in different blocks 
(for detailed information see Barch et al., 2013 ). After the scan session 
the participants performed a “Remember, Know, New ” item recognition 
test outside of the scanner. Participants were tested on the faces and 
places presented during the task in the scanner, with an equal num- 
ber (48) of new faces and places. Body parts and tools were not in- 
cluded as there were not enough new items. Participants were asked for 
each item if they had seen it before (old vs. new) and, in case of an old 
item, whether they could recollect the context of the item (remember) 
or not (know). Recollection (remembering vs. know) is thought to rely 
on hippocampus-dependent processes, while recognition (old vs. new) is 
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associated with areas such as the perirhinal cortex ( Davachi et al., 2003 ; 
Eichenbaum et al., 2007 ; Eldridge et al., 2000 ). In our analysis, we will 
focus on the 0-back condition to minimise any confound of performing 
a working memory task during the encoding phase. 
2.4. Data pre-processing 
The HCP data has already been preprocessed by the WU-Minn HCP 
consortium, to ensure data quality. Preprocessing steps are described in 
short, detailed information about the different pipelines can be found in 
Glasser et al., 2013 and Smith et al., 2013 . 
2.4.1. Structural MRI 
The structural MR pipeline consisted of three parts; the Pre- 
FreeSurfer, FreeSurfer and PostFreeSurfer pipelines. In short, the Pre- 
FreeSurfer pipeline included: undistorted native structural volume space 
production, T1w and T2w alignment, bias field correction and MNI reg- 
istration. In the FreeSurfer pipeline, the images were downsampled from 
0.7 mm isotropic to 1 mm isotropic and FreeSurfer’s recon-all was run. 
The PostFreeSurfer pipeline included producing NIFTI (volume) and 
GIFTI (surface) files, applying surface registration and downsampling 
the registered surfaces. The recon-all analysis in FreeSurfer used auto- 
mated labeling for segmentation of the T1w image into 37 neuroanatom- 
ical structures and calculated gray matter volumes (mm 3 ). Endpoints 
of interest were total brain volume, gray matter volume, white mat- 
ter volume and MTL structures (hippocampus, parahippocampal cortex, 
perirhinal cortex and entorhinal cortex ( Fischl, 2012 ; Fischl et al., 2002 ). 
As the FreeSurfer pipeline determined gray matter volumes, we also de- 
termined the gray matter density with FSL’s voxel-based morphometry 
(FSL-VBM). With the Jacobian determinants calculated to register the 
structural scan to MNI152, we determined local shape differences. 
2.4.2. Resting-state and task fMRI 
Preprocessing steps of the functional MR data included: spatial 
distortions correction, head motion correction with FMRIB’s Linear 
Image Registration Tool (FLIRT), registration to T1-weighted structural 
image, resampling to MNI space using 2mm FWHM surface smoothing, 
global intensity normalization, minimal high-pass filtering and artefact 
removal using ICA + FIX. For additional head motion correction, we 
determined the frame-wise displacement for each participant using the 
realignment parameters and excluded participants with a mean root- 
mean-square of the frame-wise displacement > 0.5 ( Oldehinkel et al., 
2019 ). Further, we checked for between-group differences. The cortical 
surface timeseries and subcortical volume time series were combined in 
a grayordinate dense time series file (CIFTI, see ( Glasser et al., 2013 )). 
2.4.3. DMN identification 
For the resting-state fMRI 25 RSNs on group-level were determined 
with an independent component analysis approach, using group ICA, 
implemented in FSL’s MELODIC (Multivariate Exploratory Linear Opti- 
mised Decomposition into Independent Components) ( Jenkinson et al., 
2012 ). The subject-specific spatial maps were estimated with the dual 
regression technique ( Nickerson et al., 2017 ); First, the group-level RSNs 
were used as regressors against each subject’s fMRI dataset in a multi- 
variate regression analysis to estimate the individual timecourses corre- 
sponding to each group-level RSN. Second, these individual timecourses 
were used as regressors against each subject’s fMRI dataset in a second 
multivariate regression analysis to estimate the subject-specific spatial 
maps ( Beckmann et al., 2009 ). The preprocessed files contain 25 subject- 
specific spatial maps for each participant. The spatial map representing 
the DMN contains the anterior cingulate cortex, posterior cingulate cor- 
tex, precuneus, medial prefrontal cortex, retrosplenial cortex, parietal 
cortex and mediotemporal lobe regions and was selected based on vi- 
sual inspection of the group ICA results. The DMNs of all participants 
were combined in one 4D file and separated in left and right hemisphere 
data using Connectome Workbench ( Marcus et al., 2013 ). 
2.4.4. Genetic analyses 
Genotyping data was extracted from blood samples using the 
Illumina Multi-Ethnic Global Array (MEGA) SNP-array, includ- 
ing chip-specific content from PsychChip and ImmunoChip. The 
data was made available by the HCP via the dbGAP repos- 
itory ( https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi? 
study_id = phs001364.v1.p1 ). We used the genotyping data to determine 
the APOE genotype in the sample. Further, we ran a PRS analysis, as 
described by Purcell et al. ( Purcell et al., 2009 ). Quality control of 
genotyping was carried out by excluding SNPs based on minor allele 
frequency (MAF < 5%), genotyping call rate (GCR < 95%) and Hardy- 
Weinberg equilibrium (HWR < 10e-6). We selected for further PRS anal- 
ysis individuals determined to be from European descent using multi- 
dimensional scaling analysis with the European 1000 Genomes dataset 
as reference 1 ; the first four components from multi-dimensional scal- 
ing analysis on individuals of European descent were tested on associa- 
tion with the MRI outcome variables using PALM (5000 permutations) 
and added as a covariate under the condition that they reported a sig- 
nificant association ( Price et al., 2006 ; Purcell et al., 2007 ). Further, 
genotypes were imputed with the European 1000 Genomes reference 
panel using RICOPILI, which included additional quality control proce- 
dure with thresholding for the quality of the imputation (INFO < 0.1), 
minor allele frequency (MAF < 5%), genotyping call rate (GCR < 80%), 
and missing rate (MR < 0.01) ( Lam et al., 2019 ). The PRS was calcu- 
lated for each participant given the effect sizes from previously pub- 
lished discovery data, using the PRSice software ( Jansen et al., 2019 ; 
Euesden et al., 2014 ). The PRS was computed as the sum of the risk- 
alleles carried by each individual in the HCP sample, weighted by their 
effect size, whereby both risk-allele and effect size were derived from 
the original (discovery) GWAS. The formula for the PRS, given OR-based 







∗ 𝑋 SNP 
where X is the number of risk alleles for the individual in the target 
sample (here the HCP sample). 
We defined the imputed genotyping data reported by HCP individu- 
als of inferred European descent as our target sample, and the genome- 
wide summary statistics of AD in European subjects reported by Jansen 
et al. as the discovery sample, which is one of the largest GWAS for AD 
to date ( Jansen et al., 2019 ). We used standard clumping in PRSice to 
adjust for linkage disequilibrium. We ran two PRS analyses: one with 
and one without the APOE allelic variants and their (correlated) vari- 
ants in linkage disequilibrium (chr19: 45020859–45844508). The P- 
value threshold for the included SNPs was based on the findings by 
Jansen et al. (2019) ; 1.69 ∙10 − 5 for the PRS with APOE variants included 
and 3.5 ∙10 − 5 for the PRS without APOE variants 2 . With the two PRS re- 
sults, we were able to determine how much of the genetic variance in 
the imaging phenotypes is explained with and without APOE. 
1 For the PRS analyses, we decided to include only participants from inferred 
European descent. We decided on this deviation before data observation as the 
genetic data of a European subset could be imputed using the European 1000 
genomes sample. Further, the summary statistics by Jansen et al. are based on 
a European sample, leading to more reliable PRSs in a European subset of par- 
ticipants. 
2 Commonly, phenotypic information is used to determine the optimal P-value 
for included SNPs in the PRS model. The imaging analyses in PALM are per- 
formed in a 4D format, which is not compatible with the PRS approach, for 
which a single phenotypic value per participant (1D vector) is needed. There- 
fore, instead of using phenotypic variance to determine the optimal P-value 
threshold of the PRS model, we used the optimal thresholds for AD prediction 
determined in the GWAS by Jansen et al. 
4 
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2.5. Statistical analyses 
2.5.1. Structural MRI 
APOE 𝜀 4-carriers and non-carriers were tested for differences in 
brain volumes, gray matter density and local shape differences (Jaco- 
bian determinants). Additionally, the association between PRS and these 
morphometric markers was tested. We used non-parametric permuta- 
tion tests (10.000 permutations) using Permutation Analysis of Linear 
Models (PALM) ( Winkler et al., 2014 , 2015 ). Permutation tests account 
for multiple comparisons and PALM specifically restricts the shuffling 
of observations that cannot be permuted freely according to exchange- 
ability blocks, which was necessary with the family structure (twins and 
non-twin siblings) in the HCP data ( Winkler et al., 2015 ). Age, gender 
and education level were added as covariates. The results were family- 
wise error rate (FWER) corrected at p < 0.05. See Fig. 1 for an overview 
of the analyses. 
2.5.2. Resting-state fMRI 
The subject-specific spatial map represents each subject’s functional 
co-activation of the DMN estimated at group level, expressed as voxel- 
wise regression coefficients. Non-parametric permutation tests were 
used to assess group differences in the subject-specific spatial maps of 
the DMN between APOE 𝜀 4-carriers and non-carriers, as well as associa- 
tion with PRS ( Winkler et al., 2015 ). Permutation tests, according to ex- 
changeability blocks, were performed with PALM. Adjacency between 
vertices of the cortical surface data was taken into account, because 
nearby vertices are not independent. We added age, gender, education 
level and head motion (mean framewise displacement) as covariates to 
the model. PALM was run separately for the left and right hemisphere 
and subcortical data (10.000 permutations, with TFCE inference), after 
which we combined the results. The results were FWER-corrected at p 
< 0.05. See Fig. 1 for an overview of the analyses. 
2.5.3. Task fMRI 
Recognition performance (old vs. new) was calculated using the d’ 
(d-prime) measure. Participants with a d’ score at or below zero were 
excluded, as this indicates a performance at or below chance level for 
old-new discrimination. The contrast of interest for the working memory 
task fMRI data was remember vs. know (i.e. recollection performance), 
which was analysed using FMRIB’s Expert Analysis Tool (FEAT) in FSL 
(v 6.0) ( Woolrich et al., 2001 ). During the analysis phase, we addition- 
ally excluded participants performing at ceiling level for recollection 
performance, since this led to rank deficiency issues in FEAT 3 . The func- 
tional activation patterns of the encoding of the images leading to either 
recollection or recognition was determined using the results of the “Re- 
member, Know, New ” item recognition test and the available timing 
of these images during the 0-back task. As the categories of the item 
recognition tests belong to different semantic categories, we analysed 
the two categories of ‘face’ and ‘place’ images both together and sep- 
arate. Higher level analyses for group differences or association with 
PRS were performed using PALM (10.000 permutations, with TFCE in- 
ference), as FMRIB’s Local Analysis of Mixed Effects (FLAME) cannot 
correct for the family structure in the HCP data. Age, gender, education 
level and head motion were included as covariates. The results were 
FWER-corrected at p < 0.05. An overview of the analyses can be seen in 
Figs. 1 and 2 . 
Filippini et al. suggested that increased DMN co-activation and in- 
creased task-related activation in APOE 𝜀 4-carriers might be a reflection 
of a compensation mechanism ( Filippini et al., 2009 ). The HCP sam- 
ple size permitted us to perform an additional test to compare DMN 
co-activation and task-related activation between APOE 𝜀 4-carriers and 
3 This concerns a change in exclusion criteria. Participants performing at ceil- 
ing level led to rank deficiency issues in FEAT during the level 1 analysis and 
therefore had to be excluded before analysis could be performed. 
non-carriers. Under the hypothesis outlined in Filippini et al., APOE 𝜀 4- 
carriers need increased DMN co-activation or task-related activation for 
matched performance to non-carriers ( Filippini et al., 2009 ). We there- 
fore corrected the task fMRI analyses of the ‘face’ category for the score 
of the item recognition test to examine whether the compensation hy- 
pothesis holds 4 . In our analysis of the compensation hypothesis, we used 
all items from the item recognition task (both 0-back and 2-back tasks) 
across categories, and for faces and places separately to compute recol- 
lection scores. New items (foils) could compete with items from both the 
2-back and 0-back tasks, which means that it is not possible to obtain a 
reliable estimate of recognition for each task independently. 
These scores were computed as: Recollection = the proportion of 
“Remember ” responses / 1 – the proportion of “Know ” responses 
( Jacoby et al., 1997 ; Prze ź dzik et al., 2019 ). Specifically, we computed 
the proportion of “Remember ” and “Know ” responses by dividing the 
number of correctly identified old items (i.e. the correct remember and 
know responses, respectively) by the total number of responses for that 
participant. Items to which participants did not respond were excluded 
from the analysis. Participants for whom one session was missing were 
also excluded. Statistical analyses of the neuroimaging data were similar 
to the resting-state fMRI and task fMRI analyses. 
2.6. Quality checks and outcome-neutral validation tests 
Extensive data quality checks were performed by the WU-Minn HCP 
Consortium with multiple levels of quality control throughout data ac- 
quisition ( Marcus et al., 2013 ). The gray matter volumes and ICA compo- 
nents have been checked for errors ( Marcus et al., 2013 ). Additionally, 
we excluded participants with anatomical anomalies and segmentation 
and surface errors in the data. Next to that, we performed an outcome 
neutral validation test for the recollection vs. recognition contrast of the 
task fMRI analysis. A whole-group analysis was performed, where we 
expected higher hippocampal activation during the encoding of images 
that are recollected, corresponding to our hypothesis that recollection 
relies on hippocampal-dependent processes. 
3. Results 
3.1. Structural MRI 
3.1.1. APOE carriership (preregistered) 
To study whether APOE 𝜀 4-carriership influences morphometric fea- 
tures, we included 787 participants. The two groups consisted of 243 
APOE 𝜀 4-carriers and 544 non-carriers. We assessed the T1-weighted 
scans using three types of morphometric analyses; gray matter density 
was determined with FSL-VBM, brain volumes were determined with 
FreeSurfer and local shape differences were assessed using the Jacobian 
determinants. No between-group differences were found for gray matter 
density (p > 0.27, t < 387.65), brain volumes (p > 0.37, t < 2.00) and local 
shape differences (p > 0.26, t < 380.76). Including covariates of age, gen- 
der and education level did not alter the results. Morphometric features 
were not different between carriers and non-carriers. 
3.1.2. Polygenic risk score (preregistered) 
For the PRS analysis of the morphometric features, we included 
625 participants of inferred European descent, with accurate detection 
of polygenic variants, and a quality-controlled T1-weighted structural 
scan. No associations of PRS, either with or without inclusion of APOE 
allelic variants, with gray matter density (p > 0.43, t < 296.33 and p > 0.16, 
t < 504.04, respectively), brain volumes (p > 0.19, t < 2.21 and p > 0.15, 
t < 2.44 respectively) and local shape differences (p > 0.26, t < 356.58 and 
4 Our results showed an increased task-related activation in the analysis of the 
separate “face ” category. Therefore, as described in the preregistered report, we 
corrected for the recollection scores of the item recognition test. The calculation 
of these scores was not previously described in the preregistered report. 
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Fig. 2. Schematic overview of the task fMRI analyses. 
p > 0.84, t < 209.31, respectively) were found using PALM. The inclusion 
of covariates of age, gender and education level did not alter the results. 
PRS was not found to be associated with morphometric features. 
3.2. Resting-state fMRI 
3.2.1. APOE carriership (preregistered) 
For the main analysis, we studied the hypothesis that APOE 𝜀 4- 
carriers show increased co-activation of the DMN. Of the 787 partic- 
ipants included in the structural MRI analysis, 586 participants also 
completed all four resting-state fMRI scans, which were reconstructed 
using the improved image reconstruction algorithm (r227). The groups 
included 167 APOE 𝜀 4-carriers and 419 non-carriers. No significant dif- 
ferences in DMN co-activation were found between APOE 𝜀 4-carriers 
and non-carriers (p > 0.37, t < 50.49). Including different combinations 
of covariates of age, gender, education level and head motion did not 
alter the results. Carriers were not found to have increased DMN co- 
activation compared to non-carriers. 
3.2.2. Polygenic risk score (preregistered) 
To study the association of PRS with DMN co-activation, we were 
able to include 454 participants in the rfMRI analysis, who completed 
all four resting-state fMRI scans with the r227 image reconstruction al- 
gorithm. No association of PRS (with or without APOE variants) with 
DMN co-activation was found (p > 0.26, t < 58.51 and p > 0.18, t < 68.37 
respectively). Results did not differ after including (different combina- 
tions of) covariates of age, gender, education level and head motion. 
DMN co-activation was not found to be influenced by PRS. 
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Table 1 
Peak clusters in APOE 𝜀 4-carriers relative to non-carriers. 
Voxel coordinates peak cluster Corresponding structure Peak p-value, 
FWER-corrected 
t-statistic 
x y z 
70 32 45 33% Left Lateral Occipital Cortex, 29% Left Angular Gyrus 0.028 887.04 
73 44 36 43% Left Middle Temporal Gyrus, 15% Left Superior Temporal Gyrus 0.034 848.90 
67 73 27 37% Left Temporal Pole, 24% Left Frontal Orbital Cortex 0.041 808.85 
23 70 55 55% Right Middle Frontal Gyrus 0.036 837.41 
21 33 60 62% Right Lateral Occipital Cortex, 25% Right Angular Gyrus 0.039 818.94 
3.3. Task fMRI 
3.3.1. APOE carriership (preregistered and post hoc analyses) 
To study functional activation patterns of recollection performance 
between carriers and non-carriers, we used the 0-back in-scanner work- 
ing memory task, which served as the encoding phase for the post- 
scanner item recognition task. We included 621 participants, who com- 
pleted both working memory scans, in addition to the inclusion criteria 
of the structural MRI analysis. 574 participants performed above-chance 
level (d’ > 0) in both the ‘face’ and ‘place’ categories of the 0-back task. 
There were no group differences in d’-score, before or after excluding 
participants that performed below-chance level. In addition, no group 
differences were detected in the excluded participants. 
The functional activation pattern during the encoding of recollec- 
tion vs. recognition was determined by linking the results of the item 
recognition task to the timing of the images during the N-back task 
in scanner. The other categories of the task were included as block 
regressors in the level 1 design. In the analysis of the combined cat- 
egories of ‘face’ and ‘place’, 386 participants could be included, who 
did not perform at ceiling level in both scans. For the planned analy- 
sis of separate categories of ‘face’ and ‘place’, we included 286 and 177 
participants, respectively. The higher-level group analyses of the com- 
bined categories ‘face’ and ‘place’ and the separate category ‘place’ did 
not show any between-group differences in functional activation during 
the encoding of subsequently recollected items (p > 0.60, t < 229.43 and 
p > 0.34, t < 305.05 respectively). However, in the higher-level analysis 
of the ‘face’ category we found a significant increased functional ac- 
tivation pattern in APOE 𝜀 4-carriers relative to non-carriers (p < 0.05, 
t > 756.11). This functional activation pattern differs from the initial 
findings of Filippini et al. (2009) , with increased activation found bilat- 
erally in the lateral occipital cortex and angular gyrus, left middle tem- 
poral gyrus, left temporal pole and right middle frontal gyrus ( Fig. 3 A, 
Table 1 ). Including different combinations of covariates of age, gender, 
education level and head motion did not alter the results. To study the 
compensation hypothesis, we performed a post hoc analysis, where we 
corrected the task fMRI analysis of the ‘face’ category for the effect of the 
score of the item recognition test. The score of the item recognition test 
was higher in APOE 𝜀 4-carriers (p = 0.02, t = 1.99), after adding the score 
as covariate to the task fMRI analysis, increased activation remained 
present (p < 0.05, t > 745.16). Functional activation patterns of recollec- 
tion performance were found to be increased in 𝜀 4-carriers in the ‘face’ 
category, the activation patterns remained increased after correcting for 
the effect of recollection performance. 
3.3.2. Polygenic risk score (preregistered and post hoc analyses) 
In addition, we studied the association of PRS with functional acti- 
vation patterns of recollection performance. A subgroup of 491 partici- 
pants of the structural MRI analysis also completed both working mem- 
ory scans. We included 459 participants who performed above-chance 
level in the 0-back task in both the ‘face’ and ‘place’ category. We found a 
normal distribution of PRS in the group both before and after excluding 
participants (Fig. S1). In addition, PRS was not associated with D’-score 
(p > 0.08). 
For the analysis of the combined ‘face’ and ‘place’ categories, we in- 
cluded 319 participants who did not perform at ceiling level in both the 
LR or RL scan. For the separate analyses of the ‘face’ and ‘place’ cate- 
gory, 249 and 138 participants were included, respectively. We did not 
find any association of PRS with functional activation patterns during 
the encoding of subsequently recollected items in the combined cate- 
gories ‘face’ and ‘place’ and the separate category ‘place’ (APOE vari- 
ants included: p > 0.26, t < 339.57 and p > 0.23, t < 318.17 respectively, 
APOE variants not included: p > 0.32, t < 346.92 and p > 0.25, t < 208.74, 
respectively). In the analysis of the ‘face’ category we did detect an 
association of increased PRS (APOE variants included) with increased 
functional activation patterns during the encoding of subsequently rec- 
ollected items (p < 0.05, t > 647.55 APOE variants not included: p > 0.37, 
t < 262.55). Increased activation is detected in the superior frontal gyrus, 
left and right lateral occipital cortex, precuneous cortex and frontal pole 
( Fig. 3 B, Table 2 ). This functional activation pattern shows overlap with 
the findings from the APOE analysis ( Fig. 3 C). Including covariates of 
age, gender, education level, head motion and the first component from 
the multi-dimensional scaling analysis did not change the results. In our 
post hoc analysis on the compensation hypothesis, we corrected the 
task fMRI analysis of the ‘face’ category for the effect of recollection. 
A higher score of the item recognition test was associated with higher 
PRS (p = 0.009, t = 2.14). Increased activation remained present (p < 0.05, 
t > 616.15) after adding the score as covariate to the task fMRI analysis. 
3.4. Quality checks 
Since we used an encoding task instead of the memory task used 
in the original study, we performed a whole-group analysis to ensure 
that encoding of images, which were afterwards recollected in the item 
recognition task, leads to higher hippocampal activation. We included 
the participants from the APOE analysis in both categories of ‘face’ and 
‘place’ (n = 386), and found that recollection vs. recognition led to signif- 
icant activation in both the left and right hippocampus (p < 0.05, FWER 
corrected), as shown in Fig. 4 . 
4. Discussion 
In this work, we aimed to replicate the early results of 
Filippini et al. (2009) in a substantially larger sample. In addition, we 
extended our replication study with a PRS-based analysis to understand 
whether polygenic contribution of common genetic variants to AD may 
influence brain structure and function in young adults. We used the 
WU-Minn HCP (S1200) dataset to analyse morphometric markers (brain 
volumes, gray matter density and local shape differences), DMN co- 
activation and working memory task-based activation. These features 
were assessed for differences between APOE 𝜀 4-carriers and non-carriers 
and for their association with PRS. 
In contrast to Filippini et al. (2009) , we did not find increased DMN 
co-activation and increased hippocampal task-based activation in APOE 
𝜀 4-carriers relative to non-carriers. In addition, we did not find any sig- 
nificant group differences in brain volumes and other morphometric 
markers. We broadened the scope of our replication by calculating a 
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Fig. 3. A: increased functional activation in APOE 𝜀 4-carriers 
over non-carriers found bilaterally in the lateral occipital cor- 
tex and angular gyrus, left middle temporal gyrus, left tempo- 
ral pole and right middle frontal gyrus. B: increased functional 
activation associated with increased PRS detected in the supe- 
rior frontal gyrus, left and right lateral occipital cortex, precu- 
neous cortex and frontal pole. C: Overlap between increased 
functional activation of APOE 𝜀 4-carriership and higher PRS. 
Table 2 
Peak clusters associated with increased PRS (APOE variants included). 
Voxel coordinates peak cluster Corresponding structure Peak p-value, 
FWER corrected 
t-statistic 
x y z 
31 26 14 Cerebellum 0.017 859.97 
48 78 57 33% Superior Frontal Gyrus, 29% Paracingulate Gyrus 0.025 777.50 
63 33 59 46% Left Lateral Occipital Cortex, 17% Left Angular Gyrus 0.019 821.38 
24 33 58 46% Right Lateral Occipital Cortex, 17% Right Angular Gyrus 0.020 813.14 
46 25 55 16% Precuneous Cortex 0.033 715.48 
30 87 53 90% Right Frontal Pole 0.032 729.37 
Fig. 4. Whole-group functional activation pattern of recollec- 
tion over recognition 
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PRS, both with and without the APOE variants. We did not find an as- 
sociation between PRS and morphometric markers, DMN co-activation 
and hippocampal task-based activation. Thus, our study on APOE 𝜀 4- 
carriership and polygenic risk for AD failed to replicate the early findings 
of Filippini et al. (2009) . However, we did find increased task-based ac- 
tivation in APOE 𝜀 4-carriers and participants with higher PRS in other 
brain areas, which could indicate that genetic risk for AD modulates 
brain function in young adults. Nevertheless, task-based activation out- 
comes vary widely between studies ( Dennis et al., 2010 ; Filippini et al., 
2009 ; Matura et al., 2014 ; Mondadori et al., 2006 ), which impedes the 
use of these neuroimaging biomarkers for early risk assessment in clin- 
ical and research settings. 
Very few studies have investigated the influence of genetic pre- 
disposition for AD on DMN co-activation in young adults. Apart from 
Filippini et al. (2009) , Su et al. (2015) have also shown an increase 
in DMN functional connectivity compared to APOE 𝜀 3 and 𝜀 2-carriers, 
while others did not find any differences between 𝜀 4 and 𝜀 3-carriers 
( Dowell et al., 2016 ). In line with Dowell et al. (2016) , we did not de- 
tect any group differences in DMN co-activation in young adults. The 
previous work has yielded mixed results in healthy young adults in the 
age range of 18-35 years old, using similar methodological protocols, 
although using small sample sizes (18-98 participants) from selective 
groups. Our study sample, representing the population at large, rele- 
vantly adds to these results. This outcome is not specific to APOE, but 
extends to the general trend of candidate gene studies in the field of 
behavioural genetics, which have usually failed to replicate the role of 
single genes in larger samples ( Flint and Munafò, 2013 ). 
In the task fMRI analysis, we studied recollection performance, by 
analysing the functional activation patterns during encoding of images 
that subsequently were recollected or recognized. We demonstrated that 
encoding of images leading to recollection over recognition was asso- 
ciated with activation in the MTL structures. While we did not repli- 
cate the findings of Filippini et al., with increased task activation in 
the hippocampal areas, we did find increased activation in APOE 𝜀 4- 
carriers relative to non-carriers during the 0-back face task in areas re- 
lated to facial recognition, such as the lateral occipital cortex and the 
area surrounding superior temporal sulcus containing the fusiform face 
area ( Freiwald et al., 2016 ). Even though APOE 𝜀 4-carriers had a higher 
recollection performance than non-carriers, when controlling for this ef- 
fect, increased task activation was still detected. Although we found in- 
creased task activation in other areas, this could mean that APOE 𝜀 4- 
carriers need higher activation to recollect faces, indicating towards 
the compensation hypothesis proposed by Filippini et al. (2009) and 
Matura et al. (2014) . Our findings add to the wide variation in outcome 
shown in earlier studies on task-based activation: APOE 𝜀 4-carriers were 
found to have both increased ( Dennis et al., 2010 ; Filippini et al., 2009 ; 
Matura et al., 2014 ) and decreased ( Mondadori et al., 2006 ) hippocam- 
pal task-related activation compared to non-carriers during both encod- 
ing and memory retrieval tasks. 
In line with the results from Filippini et al. (2009) , we found no 
differences in morphometric features between the APOE 𝜀 4-carriers and 
non-carriers. While Filippini et al. (2009) focused on assessing brain vol- 
umes using VBM, we assessed morphometric features in depth, studying 
brain volumes, gray matter density and local shape differences. Like ear- 
lier research on DMN co-activation and task activation, outcomes varied 
widely across studies; some found no differences between APOE carriers 
and non-carriers ( Filippini et al., 2009 ; Khan et al., 2014 ; Matura et al., 
2014 ; Su et al., 2015 ), while others detected reduced hippocampal vol- 
ume ( Alexopoulos et al., 2011 ; O’Dwyer et al., 2012 ) or reduced entorhi- 
nal thickness ( Shaw et al., 2007 ). However, these results could be driven 
by the larger hippocampal volume and entorhinal thickness found in 
𝜀 2-carriers, who are not included in our study ( Alexopoulos et al., 
2011 ; Shaw et al., 2007 ). Consequently, although we are 
currently unable to make any conclusive remarks, the results are 
supportive for none to limited genetic effects on morphometric features 
in young, healthy adults. 
We extended our replication with a PRS analysis, which allows for 
data-driven investigation of the aggregated effects of many common 
risk variants as determined in a large European GWAS ( Chasioti et al., 
2019 ; Jansen et al., 2019 ). AD case-control studies show increased pre- 
diction accuracy when using PRS, identifying high-risk individuals be- 
yond APOE 𝜀 4-carriership ( Chouraki et al., 2016 ; Desikan et al., 2017 ; 
Escott-Price et al., 2015 ; Tan et al., 2017 ). We used the summary statis- 
tics of the large GWAS by Jansen et al. (2019) , who included clini- 
cally diagnosed AD patients, as well as ‘AD-by-proxy’ cases, based on 
parental diagnoses of AD, who show a strong genetic correlation with 
AD (r g = 0.81). They estimated the PRS with APOE explains 7.1% of the 
variance in clinical AD and PRS without APOE 3.9%. Despite this in- 
creased sensitivity, few studies have been performed on the association 
between polygenic risk and AD imaging phenotypes. In older adults, 
increased polygenic risk was associated with reduced hippocampal vol- 
ume ( Foo et al., 2021 ; Lupton et al., 2016 ) and entorhinal cortex vol- 
ume ( Desikan et al., 2017 ) as well as annual cortical and hippocampal 
thinning rates ( Harrison et al., 2016 ; Sabuncu et al., 2012 ). First stud- 
ies in healthy young adults reported an association between higher PRS 
and decreased hippocampal volume ( Foley et al., 2017 ; Walhovd et al., 
2020 ) and decreased left precuneus volume ( Li et al., 2018 ). These re- 
sults are in contrast with our findings, using one of the largest GWAS 
for AD to date. Unlike the previous studies in young adults, all using the 
AD case-control GWAS by Lambert et al. (2013) , the GWAS summary 
statistics we used to build our PRS include ‘AD-by-proxy’ individuals. 
Despite the strong correlation between AD diagnosis and ‘AD-by-proxy’ 
cases based on parental diagnoses, our non-significant results may be 
a consequence of the ‘AD-by-proxy’ cases. By including these partici- 
pants, who will not necessarily be diagnosed with AD in later life, we 
may have included irrelevant genetic factors in the analysis, leading to 
additional noise. Furthermore, since PRS-AD associations are more con- 
sistently found in samples with older adults, and the lifespan analysis by 
Walhovd et al. (2020) could not exclude an aging effect, we could spec- 
ulate that risk for AD is driven by genetic factors whose effects become 
more pronounced at a later stage. 
While the original findings could be a false positive, meaning that ge- 
netic risk for AD does not modulate brain function at a young age there 
are also several possible explanations for the failure to replicate the orig- 
inal findings of Filippini et al. (2009) . Firstly, there are methodological 
differences between our study and Filippini et al. (2009) even though we 
adhered to their methods as much as possible. The specific deviations 
from the original study, such as advanced data preprocessing and choice 
of working memory task, were outlined in Section 2.1 . Although not ex- 
pected, these deviations, for example using an encoding task instead of 
a memory retrieval task, could have led to a failure to replicate the in- 
creased hippocampal activation in APOE 𝜀 4-carriers. Furthermore, our 
results could be related to lower SNR in the subcortical areas compared 
to Filippini et al. (2009) , as the HCP favours higher spatial resolution 
in the trade-off between the two ( Smith et al., 2013 ). Secondly, using a 
significantly larger study sample will likely result in increased hetero- 
geneity in the sample, leading to a “regression to the mean ” effect, where 
outcomes tend to be closer to the population mean ( Held et al., 2020 ; 
Senn, 2011 ). Similar effects were established e.g. in the field of psychi- 
atry, where, in patient vs. control prediction, accuracy of group delin- 
eation decreases with increasing sample size ( Wolfers et al., 2015 ). If we 
are indeed dealing with regression to the mean and a true non-null find- 
ing, the previous findings of Filippini et al. (2009) are suggested to be 
specific to a subpopulation. Thirdly, in case Filippini et al. (2009) have 
truly discovered a non-null effect in their small sample of 36 partici- 
pants, the observed effect size is likely inflated, also known as the “win- 
ner’s curse ” ( Button et al., 2013 ; Ioannidis, 2008 ). This impacts on repli- 
cation studies, as the true effect is expected to be smaller. However, a 
true non-null effect is unlikely, as our large sample size provides power 
to detect much smaller effect sizes than the effect reported previously. 
Fourthly, as described above, there are limited studies on this subject, 
performed with mostly small samples, which show a wide variation in 
9 
L.J. Mentink, J.P.O.F.T. Guimarães, M. Faber et al. NeuroImage 240 (2021) 118304 
outcome. Expectedly, only few report no effects. We can only speculate 
as to whether we are dealing with publication bias, as negative findings 
in small studies are often rejected by journals, also known as the “file 
drawer problem ” ( Button et al., 2013 ). 
In sum, we were not able to replicate the effect of APOE 𝜀 4- 
carriership on brain function in young adults. In addition, we broadened 
the scope of the original study by incorporating PRSs, thereby incorpo- 
rating additional risk for AD beyond APOE 𝜀 4-carriership. Taking the 
methodological considerations of replication studies into account, the 
true effect of APOE 𝜀 4-carriership in the broader population is likely 
smaller than indicated in the original Filippini paper. Speculating on 
the effect being smaller or even not present, this would lead to several 
clinical implications. 
The previous findings are generally cited to demonstrate that brain 
function is modulated in APOE 𝜀 4-carriers decades before clinical rep- 
resentation of AD ( Hafkemeijer et al., 2012 ; Huang and Mucke, 2012 ; 
Jack et al., 2010 ; Liu et al., 2013 ). In studies with older adults, altered 
DMN co-activation is seen before other biomarkers, such as amyloid- 
B deposition measured in PET and CSF, appear ( Jack et al., 2013 ; 
Sheline et al., 2010 ). Failure to replicate findings on early AD biomark- 
ers such as the DMN impacts the understanding of the preclinical AD 
stage, currently thought to begin decades before clinical expression 
of the disease ( Sperling et al., 2011 ). This is relevant as many drug 
trials including elderly subjects with AD have not been successful, 
and plead for new, longer trials with asymptomatic, at-risk individu- 
als ( Schneider, 2017 ). Thus, the understanding of this early preclinical 
stage is very important, since this group is targeted for primary preven- 
tion and prodromal therapeutic trials ( Dubois et al., 2016 ; Sperling et al., 
2011 ). However, solely focusing on (neuroimaging) biomarkers to un- 
ravel the mechanistic pathway of AD will probably not solve the AD 
conundrum. Moreover, having AD pathology does not equal having de- 
mentia and cognitive impairment ( Hachinski, 2019 ). Therefore, further 
research should be more broadly focused on the interactions of genetic 
risk, biomarkers, aging and lifestyle factors over the life course, and 
sensitive functional neuroimaging as used here may help disentangling 
these complex interactions. 
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